Efficacy and Safety of Intraarticular Injections of Hyalgan in the Treatment of Osteoarthritis of the Knee
Evaluate the efficacy and safety of Hyalgan, at a dose of 20mg/2ml administered as 5 intraarticular injections at weekly intervals, for the sustained relief of pain and amelioration of joint dysfunction in patients of OA of the knee.
|Study Design:||Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind (Subject, Caregiver)
Primary Purpose: Treatment
|Official Title:||Efficacy and Safety of Intraarticular Injections of Hyalgan in the Treatment of Osteoarthritis of the Knee: a Randomized, Masked Observed, Double Blind, Placebo Controlled, Multicenter Clinical Trial.|
|Study Start Date:||May 2001|
|Study Completion Date:||June 2002|
|Primary Completion Date:||June 2002 (Final data collection date for primary outcome measure)|
|Placebo Comparator: sterile normal saline injection||
Device: sterile normal saline
Patients will receive intraarticular injection of sterile normal saline once a week for 5 consecutive weeks.
|Experimental: Hyalgan injection||
Patients will receive intraarticular injection of 20mg /2ml /syringe Hyalgan® once a week for 5 consecutive weeks.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01319461
|National taiwan university hospital|
|Taipei, Taiwan, 100|
|Principal Investigator:||Lin Ching Tsai, PhD||National Taiwan University Hospital|